Stock listing
Dusseldorf:R9Q Recce Pharmaceuticals Ltd. Aktie
German listing (Dusseldorf) of Recce Pharmaceuticals Ltd. · home listing ASX:RCE
Follow Recce Pharmaceuticals Ltd. into a list and get an email when it puts out news.
Home listing price · ASX:RCE
$0.36 AUD 0.00 (0.0%)
Delayed at least 15 minutes · 10:30 AM GMT+11, Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, ASX:RCE
- Day range so far
- $0.36 – $0.365 AUDDelayed at least 15 minutes · 10:30 AM GMT+11, Nov 2, 2026
- Volume
- 88,474 sharesDelayed at least 15 minutes · 10:30 AM GMT+11, Nov 2, 2026
- Market cap
- $110.1M AUDDelayed at least 15 minutes · 10:30 AM GMT+11, Nov 2, 2026 · price × 305.8M shares outstanding
- 52-week range
- $0.265 – $0.73 AUDLowest and highest trades, Nov 3, 2025 – Nov 1, 2026
- Traded on an average day
- $90,408 AUDMedian day 69,173 shares · last 3 months, Aug 3, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:RCE · Home | $0.36 AUD | 0.00 (0.0%) | 88,474 | $0.365 | $0.365 | $0.36 | $0.36 | Delayed 15+ min · 10:30 AM GMT+11, Nov 2, 2026 |
| Frankfurt:R9Q | €0.192 EUR | +0.016 (+9.1%) | — | €0.204 | €0.204 | €0.192 | €0.176 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Oct 30, 2026 · ASX:RCE · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.36 | +0.03 | +9.1% | $0.345 | $0.365 | $0.345 | 10,314,707 | |
| $0.33 | +0.015 | +4.8% | $0.315 | $0.35 | $0.315 | 255,143 | |
| $0.315 | +0.005 | +1.6% | $0.30 | $0.315 | $0.29 | 293,597 | |
| $0.31 | -0.015 | -4.6% | $0.325 | $0.325 | $0.305 | 202,951 | |
| $0.325 | -0.01 | -3.0% | $0.345 | $0.345 | $0.325 | 40,554 | |
| $0.335 | -0.01 | -2.9% | $0.34 | $0.345 | $0.335 | 126,535 | |
| $0.345 | -0.01 | -2.8% | $0.35 | $0.35 | $0.335 | 69,173 | |
| $0.355 | +0.005 | +1.4% | $0.355 | $0.355 | $0.33 | 203,787 | |
| $0.35 | +0.06 | +20.7% | $0.295 | $0.365 | $0.29 | 744,674 | |
| $0.29 | 0.00 | 0.0% | $0.29 | $0.29 | $0.28 | 93,370 | |
| $0.29 | +0.01 | +3.6% | $0.285 | $0.30 | $0.28 | 86,627 | |
| $0.28 | -0.01 | -3.4% | $0.28 | $0.285 | $0.28 | 15,301 | |
| $0.29 | +0.025 | +9.4% | $0.27 | $0.29 | $0.268 | 43,027 | |
| $0.265 | -0.025 | -8.6% | $0.285 | $0.285 | $0.265 | 147,062 | |
| $0.29 | -0.005 | -1.7% | $0.295 | $0.295 | $0.285 | 81,770 | |
| $0.295 | +0.01 | +3.5% | $0.295 | $0.295 | $0.29 | 159,466 | |
| $0.285 | -0.03 | -9.5% | $0.298 | $0.298 | $0.285 | 130,772 | |
| $0.315 | 0.00 | 0.0% | $0.315 | $0.315 | $0.295 | 14,609 | |
| $0.315 | +0.01 | +3.3% | $0.31 | $0.315 | $0.29 | 339,051 | |
| $0.305 | -0.02 | -6.2% | $0.32 | $0.32 | $0.30 | 121,963 | |
| $0.325 | +0.015 | +4.8% | $0.31 | $0.325 | $0.305 | 138,718 | |
| $0.31 | -0.005 | -1.6% | $0.31 | $0.315 | $0.31 | 18,813 | |
| $0.315 | -0.01 | -3.1% | $0.325 | $0.325 | $0.305 | 91,902 | |
| $0.325 | -0.005 | -1.5% | $0.335 | $0.335 | $0.31 | 116,595 | |
| $0.33 | 0.00 | 0.0% | $0.335 | $0.34 | $0.32 | 38,272 | |
| $0.33 | 0.00 | 0.0% | $0.335 | $0.34 | $0.325 | 74,377 | |
| $0.33 | -0.005 | -1.5% | $0.335 | $0.335 | $0.325 | 154,673 | |
| $0.335 | +0.01 | +3.1% | $0.338 | $0.34 | $0.33 | 43,877 | |
| $0.325 | -0.015 | -4.4% | $0.335 | $0.335 | $0.32 | 42,970 | |
| $0.34 | -0.005 | -1.4% | $0.345 | $0.345 | $0.33 | 13,655 | |
| $0.345 | +0.01 | +3.0% | $0.34 | $0.345 | $0.338 | 25,466 | |
| $0.335 | +0.005 | +1.5% | $0.338 | $0.338 | $0.335 | 19,844 | |
| $0.33 | +0.01 | +3.1% | $0.325 | $0.335 | $0.325 | 69,748 | |
| $0.32 | -0.03 | -8.6% | $0.35 | $0.355 | $0.32 | 277,844 | |
| $0.35 | -0.005 | -1.4% | $0.35 | $0.35 | $0.345 | 22,304 | |
| $0.355 | -0.015 | -4.1% | $0.37 | $0.37 | $0.355 | 40,381 | |
| $0.37 | +0.015 | +4.2% | $0.355 | $0.37 | $0.345 | 97,134 | |
| $0.355 | -0.015 | -4.1% | $0.37 | $0.37 | $0.35 | 29,672 | |
| $0.37 | +0.01 | +2.8% | $0.36 | $0.37 | $0.345 | 242,532 | |
| $0.36 | -0.01 | -2.7% | $0.365 | $0.365 | $0.355 | 59,963 | |
| $0.37 | +0.01 | +2.8% | $0.365 | $0.37 | $0.355 | 75,875 | |
| $0.36 | 0.00 | 0.0% | $0.375 | $0.375 | $0.36 | 27,753 | |
| $0.36 | 0.00 | 0.0% | $0.37 | $0.37 | $0.355 | 41,259 | |
| $0.36 | -0.015 | -4.0% | $0.375 | $0.375 | $0.355 | 130,690 | |
| $0.375 | +0.008 | +2.0% | $0.37 | $0.375 | $0.36 | 55,429 | |
| $0.368 | -0.008 | -2.0% | $0.375 | $0.375 | $0.365 | 116,709 | |
| $0.375 | -0.005 | -1.3% | $0.38 | $0.38 | $0.37 | 189,511 | |
| $0.38 | +0.005 | +1.3% | $0.38 | $0.385 | $0.37 | 100,215 | |
| $0.375 | +0.005 | +1.4% | $0.37 | $0.375 | $0.368 | 38,796 | |
| $0.37 | +0.005 | +1.4% | $0.375 | $0.375 | $0.37 | 21,429 | |
| $0.365 | -0.01 | -2.7% | $0.375 | $0.375 | $0.365 | 230,817 | |
| $0.375 | -0.01 | -2.6% | $0.385 | $0.385 | $0.375 | 34,406 | |
| $0.385 | +0.005 | +1.3% | $0.383 | $0.385 | $0.375 | 23,226 | |
| $0.38 | -0.005 | -1.3% | $0.385 | $0.385 | $0.375 | 13,762 | |
| $0.385 | +0.015 | +4.1% | $0.375 | $0.385 | $0.375 | 31,851 | |
| $0.37 | -0.005 | -1.3% | $0.38 | $0.38 | $0.37 | 29,428 | |
| $0.375 | 0.00 | 0.0% | $0.37 | $0.375 | $0.37 | 36,019 | |
| $0.375 | -0.01 | -2.6% | $0.38 | $0.385 | $0.37 | 69,391 | |
| $0.385 | 0.00 | 0.0% | $0.385 | $0.385 | $0.375 | 62,051 | |
| $0.385 | +0.01 | +2.7% | $0.375 | $0.385 | $0.375 | 47,133 | |
| $0.375 | -0.005 | -1.3% | $0.38 | $0.385 | $0.37 | 54,492 | |
| $0.38 | +0.005 | +1.3% | $0.375 | $0.385 | $0.375 | 45,217 | |
| $0.375 | 0.00 | 0.0% | $0.375 | $0.385 | $0.375 | 7,916 | |
| $0.375 | -0.005 | -1.3% | $0.38 | $0.38 | $0.375 | 6,060 | |
| $0.38 | +0.01 | +2.7% | $0.37 | $0.38 | $0.365 | 120,803 |
- Ticker
- Dusseldorf:R9Q
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Oct 30, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 42 slides
Latest news
Quarterly Activities/Appendix 4C Cash Flow Report
Oct 29, 2026
Closed $0.36 (+9.1%) on Oct 30, 2026
License and Commercialisation Agreement in AUS/NZ for R327G
Oct 21, 2026
Closed $0.345 (-2.8%) on Oct 22, 2026
Independent Review of Indonesian Phase 3 R327G Trial Data
Oct 19, 2026
Closed $0.35 (+20.7%) on Oct 20, 2026
Amendments to Debt Facility with Avenue Capital Group
Oct 16, 2026
Closed $0.29 (+3.6%) on Oct 16, 2026
Appendix 4E and FY26 Annual Report
Aug 31, 2026
Closed $0.36 (-4.0%) on Sep 1, 2026
HREC Approves Comparator Study for Pivotal Phase 3 DFI
Aug 18, 2026
Closed $0.385 (+1.3%) on Aug 19, 2026
Vietnamese Patent Granted for RECCE Anti-Infectives
Jul 13, 2026
Closed $0.385 (-1.3%) on Jul 14, 2026
AUD $3.7M Income Tax Refund Received
Jun 30, 2026
Closed $0.38 (-6.2%) on Jul 1, 2026
Placement & SPP to raise $8 million
Jun 25, 2026
Closed $0.40 (-13.0%) on Jun 26, 2026
HREC Approval Accelerates Global Phase 3 DFI Strategy
Jun 21, 2026
Closed $0.485 (+1.0%) on Jun 22, 2026
Financings
Secured debt facility with warrants
Oct 16, 2026
Terms changed: Warrants at A$0.29
Buyers: Avenue Capital Group (lender under the existing secured debt facility)
Use of proceeds: Financial flexibility to support ongoing Phase 3 clinical trial programs
Decks
Investor Presentation (October 2026)
Investor deck · 42 slides · October 2026
Shareholder Meeting (September 2026)
Shareholder meeting · 10 slides · Sep 2, 2026
Investor Presentation (September 2026)
Investor deck · 42 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 40 slides · August 2026
Recce Pharmaceuticals Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 244 in all · newest Oct 30, 2026 · oldest 2016
- Decks
- 26 decks · latest October 2026
Where Recce Pharmaceuticals Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:RCE · Home listing | ASX | Australia | AUD |
| LS Exchange:A2ADQM | LS Exchange | Germany | EUR |
| Stuttgart:R9Q | Stuttgart | Germany | EUR |
| Lang & Schwarz:A2ADQM | Lang & Schwarz | Germany | EUR |
| gettex:R9Q | gettex | Germany | EUR |
| Frankfurt:R9Q | Frankfurt | Germany | EUR |
| OTC:RECEF | OTC | United States | USD |
| Dusseldorf:R9Q · This page | Dusseldorf | Germany | EUR |
| Munich:R9Q | Munich | Germany | EUR |
| Tradegate:R9Q | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Recce Pharmaceuticals Ltd.